Identification association of drug-disease by using functional gene module for breast cancer

Area of Science:

• Oncology
• Pharmacology
• Bioinformatics

Background:

• Efficient development of low-risk oncology drugs is crucial.
• Computational methods are increasingly vital in drug discovery.
• Identifying shared gene modules between drugs and diseases is underexplored.

Purpose of the Study:

• To develop a novel computational method for identifying repositioned drugs for breast cancer.
• To integrate breast cancer survival data with drug sensitivity information.
• To discover potential drug candidates for breast cancer therapy.

Main Methods:

• Developed a novel computational approach for drug repositioning.
• Integrated patient survival data specific to breast cancer.
• Incorporated drug sensitivity data for candidate drugs.
• Filtered 140 potential drug candidates.

Main Results:

• Identified 4 U.S. Food and Drug Administration (FDA)-approved drugs.
• Successfully pinpointed 2 known breast cancer therapeutic drugs from the candidates.
• The method demonstrated efficacy in identifying relevant drugs.

Conclusions:

• The novel computational method effectively identifies repositioned drugs for breast cancer.
• The findings highlight potential new therapeutic options for breast cancer patients.
• This approach can accelerate the development of safe and effective cancer treatments.